Internal Medicine, Rheumatology · Campbell, CA
NPI
1497839864
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
50 E Hamilton Ave Ste 200
Campbell, CA, 95008
Phone (408) 866-1135
Groups this clinician bills Medicare through
Medicare paid, 2024
$657K
86,624 services
Medicare patients, 2024
628
Average age 75
Drug cost, 2024
$2.0M
2,815 prescriptions
Company payments, 2025
$84.68
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yong S Lee was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 66,800 times for 18 patients. In total Yong S Lee billed 86,624 services in 32 codes, and Medicare paid $657K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 66,800 | 18 | $3.60 | $241K |
| J0897 Injection, denosumab, 1 mg | Office | 12,361 | 123 | $20.58 | $254K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,320 | 40 | $0.10 | $444 |
| 99214 Office E&M - Established | Office | 927 | 529 | $113.63 | $105K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 770 | 484 | $14.51 | $11K |
| 96372 Injection Administration | Office | 632 | 177 | $14.07 | $8,895 |
| 99213 Office E&M - Established | Office | 176 | 130 | $81.64 | $14K |
| 99205 Office E&M - New | Office | 68 | 68 | $199.41 | $14K |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $38.22 | $573 |
| 90662 Vaccine Product | Office | 13 | 13 | $81.82 | $1,064 |
| 20610 Joint Injection | Office | 12 | 11 | $64.29 | $771 |
By year: 2022 $1.2M for 128,754 services; 2023 $780K for 95,566 services; 2024 $657K for 86,624 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yong S Lee prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 391 prescriptions and refills. In total Yong S Lee wrote 2,815 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 391 | 1,025 | 138 | $26K |
| Prednisone Generic | 230 | 430 | 65 | $3,633 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 228 | 237 | 50 | $12K |
| Celecoxib Generic | 161 | 307 | 49 | $6,931 |
| Methotrexate Methotrexate Sodium | 147 | 360 | 53 | $6,972 |
| Alendronate Sodium Generic | 146 | 381 | 45 | $1,264 |
| Tramadol Hcl Generic | 134 | 134 | 37 | $1,518 |
| Gabapentin Generic | 118 | 215 | 37 | $1,984 |
| Allopurinol Generic | 72 | 214 | 25 | $778 |
| Leucovorin Calcium Generic | 56 | 150 | 17 | $5,227 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 46 | 46 | 14 | $1,024 |
| Duloxetine Hcl Generic | 44 | 94 | Under 11 | $1,008 |
| Zolpidem Tartrate Generic | 41 | 43 | Under 11 | $145 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 38 | 38 | Under 11 | $1,075 |
| Meloxicam Generic | 37 | 80 | 20 | $329 |
Brand drugs: - claims; generic drugs: 2,513 claims; opioid claims: 509.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yong S Lee $84.68 ($84.68 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $84.68.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 4 | $84.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.